Male breast cancer: finding the way in this uncommon path

por Maurer, Christian, Martel, Samuel, de Azambuja, Evandro
Publicado 2017

Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis

por Brandão, Mariana, Maurer, Christian, Ziegelmann, Patricia Klarmann, Pondé, Noam F, Ferreira, Arlindo, Martel, Samuel, Piccart, Martine, de Azambuja, Evandro, Debiasi, Márcio, Lambertini, Matteo
Publicado 2020

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis

por Poggio, Francesca, Bruzzone, Marco, Ceppi, Marcello, Conte, Benedetta, Martel, Samuel, Maurer, Christian, Tagliamento, Marco, Viglietti, Giulia, Del Mastro, Lucia, de Azambuja, Evandro, Lambertini, Matteo
Publicado 2018

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer

por Agostinetto, Elisa, Ameye, Lieveke, Martel, Samuel, Aftimos, Philippe, Pondé, Noam, Maurer, Christian, El-Abed, Sarra, Wang, Yingbo, Vicente, Malou, Chumsri, Saranya, Bliss, Judith, Kroep, Judith, Colleoni, Marco, Petrelli, Fausto, Del Mastro, Lucia, Moreno-Aspitia, Alvaro, Piccart, Martine, Paesmans, Marianne, de Azambuja, Evandro, Lambertini, Matteo
Publicado 2022